11:30pm (EST)
1. Market Summary
2. Symantec (SYMC) – A Falling Knife or Ready to Rebound?
3. Earnings
4. Weekly Wrap Portfolio Update
5. Week Ahead
1. Market Summary
“The bears are crying wolf once again but after a year of false breakdowns we have become accustomed to their catcalls. While we correctly predicted a test to our near-term downside targets, we remained patient as we said there were bullish signs support would hold. However, there were a few bearish developments late on Friday that showed signs there could be be further weakness.
We were ready for another 2-step downslide like the one the market experienced in late January and into February with the bears playing the geopolitical tension card. The flop was Monday through Wednesday’s action with the turn on Thursday and Friday. The bears went all-in again and could be reloading if there is a bounce on Monday and how we are playing this week.
There are other bearish developments that will at some point derail the bulls and they could come this week depending on what the zombies do but let’s take a look at some other indicators we are watching.
We wanted to talk about the tremendous rebound in Gold that has lasted throughout the year after the yellow-metal bottomed in December and finished Friday at $1,182 an ounce. We correctly predicted a back test to $1,200 last year and we said a “double-bottom” could be forming down near $1,175 in December. We figured a back test to $1,200-$1,250 was a given and when $1,300 cleared, we took notice.
The move above the 200-day MA in February has been bullish and there are “golden crosses” forming with the 50-day MA crossing over the 100-day MA and rapidly approaching the 200-day MA. Friday’s high reached $1,388 an ounce and near-term resistance at $1,400 could be cleared this week. There is additional overhead resistance at $1,450 and a move above this level could easily lead to a run to $1,500. There is risk down to $1,350 and would suggest additional selling pressure on a close below this level. If this were the case, $1,300 could be tested and where buyers might step in as long as the 200-day MA holds.
Silver also bottomed in December at $19 and while we were hoping to load the truck up at $17.50, we never got the chance. Friday’s high reached $21.80 with a close at $21.46. Short-term resistance is at $22. A close above this level could lead to a near-term run to $23-$24. Support is at $20.
One major worry we are watching is the destruction in Copper which closed below $3 on Friday. As you can see from the 5-year weekly chart, Copper is in the process of testing it mid-2010 lows and a close below $2.75 would suggest further weakness. We have talked about Copper being a great barometer of global growth as a print above $3 indicates demand is steady but not great. As copper drops, stocks tend to follow, especially Chinese stocks, which have a strong correlation to copper.
There are worries that the recent Chinese data is leading to a massive slow down in the country that has been growing for some time. The country’s head zombie stated the country’s economy may underperform in the months ahead and could drop below 7.5% growth.
The recent corporate debt defaults are also troubling and could lead a “Lehman” moment at some point as they are only likely to increase. China may be letting more skeletons out of their closets as the government has said there won’t be any bailouts. We are looking forward to the day Wall Street doesn’t worry as much about China but this is an ominous sign for the world’s second-largest economy and could cause ripple effects down the road. For now, these developments seem to be in in the rearview mirror.
We are watching the Financials like a hawk as we have mentioned they needed to show some leadership on the next leg higher. While we have our favorites, a quick snapshot of the sector to see if there is strength or weakness, we suggest following the Financial Select Spiders (XLF, $21.80, down $0.14). The index is on the verge of testing its 50-day MA and a close below $21.50 would suggest further weakness down to $20. We would like to see support hold and a rally back above $22 this week.
A positive catalyst could be the upcoming bank stress tests results that are conducted on the largest US banks to determine how prepared they are to withstand another financial crisis if one were to happen.
The Federal Reserve will release these results on Thursday and the news should be very favorable for the market. The tests are required under the banking reform legislation the zombies passed after the 2008 financial crisis and will include the results for J.P. Morgan Chase (JPM), Bank of America (BAC), Citigroup (C), Goldman Sachs (GS) and Wells Fargo (WFC).
We have a possible call option trade on another Financial stock on our Daily Watch List that could be an active trade this week if the Financial stocks show some strength. Last year, similar zombie tests showed 17-of-18 of the largest US banks could easily withstand a possible economic meltdown worse than the 2008 crisis but let’s hope we never have to experience that again.
There are additional test results that will be released next week on Wednesday that will show if banks are holding adequate levels of capital required under the new reforms. Both results will be come after the market closes at 4pm. This will make March option expiration Friday that much more interesting.
Obama has issued some “tough words” for Putin and Russia and possible sanctions by the US and other European countries could come this week following the vote for Crimea to join with Russia late Sunday night.
The talking heads will babble about the 95% support rate but the ballot had only two questions with the only possible answer to each question being “yes”. The people voting could only check one box and if two were checked, the vote was discarded. If none were checked, the zombies probably checked one of them to make it look official. It was “dummy-proof” so it didn’t matter which box was x-ed.
The baked-in-the-cake outcome will cause additional zombie rhetoric on Monday and possible US and European sanctions. Reports are Putin used “his phone (no pen)” to call Obama and ease concerns.
We aren’t sure if Putin told the President if there are 80,000 Russian troops on the ground, 270 tanks, nearly 200 armored vehicles, 90 “get to the” choppers (sorry, we couldn’t resist), 20 ships, 140 military aircraft, and 380 artillery weapons surrounding Crimea.
We mentioned last week Putin was slow-playing this situation but another fear is that China could enter the controversy and retaliate against any Russian sanctions. Stay tuned.
Trading ranges lead to breakouts or breakdowns, and the longer they are, the more powerful they can be. Our feeling is the current range is only temporary and although it did get stretched to the downside there is further stretch to the upside.
Good or bad – geopolitical headlines, the economy, China, and upcoming 1Q earnings will all play a major role in determining the next trend. If the sanctions are seen as a slap on the wrist, the markets could rebound. However, if the saber-rattling turns worse with aggression, the bears could be joining the attack with lower levels on their map.” (from 3/16/2014 Weekly Wrap…)
The market rebounded to start the week as the Ukraine/ Russia threat simmered down but the bulls hit a speed bump halfway through after Fed Head, Janet Yellen, spooked the market.
The Financial stocks showed some strength and led Thursday’s recovery on hopes of the major banks passing the Federal Reserve’s stress test and they did. The indexes ended just below resistance going into Friday’s action and made a run for the hills but the bears we not ready to give up the white flag as selling pressure took over. The bears won Friday’s musical chairs but the bulls got the weekly win. (continued…)
The Dow fell 28 points, or 0.2%, to close at 16,302 on Friday. The blue-chips started the week with a run 16,270 and cleared the first wave of resistance at 16,200 with the close at 16,247. Tuesday’s surge to 16,369 intraday cleared the second level of resistance but the index finished just below this level at 16,336. We mentioned this was a signal a back test would come and Wednesday’s low reached 16,126 with a finish at 16,222. Thursday’s low reached 16,160 before a run to 16,351 and close at 16,331. Friday’s high reached 16,456 before 16,290 was tested into the close. We were pulling for a finish above 16,400-16,350 that would confirm a possible run at 16,500-16,600. Our fluff target remains 16,800-17,000 into April as long as support at 16,200-16,000 holds. For the week, the Dow jumped 237 points, or 1.5%, after starting at 16,065 but is still down 274 points, or 1.7%, for 2014.
The S&P 500 slipped 5 points, or 0.3%, to settle at 1,866 to end the week. The index cleared its first hurdle at 1,850 shortly after Monday’s open and the run to 1,862 ended with a close at 1,858. Tuesday’s peak reached 1,873.76 and came within spitting distance of clearing 1,875 but the bulls missed their mark by 3 points. Wednesday’s top touched 1,874.14 before the bears ended the session by pushing 1,850 and celebrating with a 12-pack win to 1,860. There was further weakness to 1,854 on Thursday’s open before the bulls woke up and made a run to 1,873 while finishing a point off the high. Friday’s intraday peak set another all-time record high of 1,883.97 before another back test to 1,860 with a low of 1,863. Prior resistance will try to hold at 1,850 again as support but any dips below 1,840 could lead to 1,825-1,800 and would signal a possible trend change. However, we have said another close above 1,875 should get 1,885-1,900 in play. We have gone on record and said we expect a run to 1,909 before a possible pullback – as long as the uptrend line holds. The S&P 500 came into the week at 1,841 and was up 25 points, or 1.4%, by Friday’s close. For the year, the index has gained 18 points, or 1%.
The Nasdaq dropped 42 points, or 1%, to close at 4,276. Tech traded to a high of 4,301 and easily cleared 4,250 with Monday’s open of 4,274. Although the index fell just shy of holding the first level of resistance we mentioned the 4-point close above 4,275 was bullish. Tuesday’s run challenged the second wave of toughness at 4,350 as the bulls made the charge to 4,334 look easy. However, when there was no follow through on Wednesday’s one point pop up to 4,334 again on the open, we felt another test to 4,300-4,275 could come. Friday’s high reached 4,344 before the bears pushed a low of 4,268. The bulls will try again this week to clear and hold 4,350 that could lead to 4,400-4,500 over the near-term. The bears came close to getting their close below 4,275 and if they do, it could lead to another test to 4,250-4,200. The Nasdaq was at 4,245 coming into the week and added 31 points, or 0.7%. Tech has advanced 100 points, or 2.4%, year-to-date.
The Russell 2000 declined 5 points, or 0.4%, to end at 1,193 on Friday. The small-caps reached a peak of 1,196 to start the week and closed at 1,186. We had a feeling resistance at 1,200 would be hard to clear on the first day back but the close above 1,175 again was bullish. Tuesday’s all day trip into green territory with a close at the peak of 1,205.04. We were mildly bullish but when Wednesday’s open only reached 1,205.36, we knew there could be some weakness after the Fed news. The close at 1,195 lead to some opening weakness on Thursday as 1,190 was tested but the bulls cleared 1,200 ahead of the bell and just missed holding resistance by a point. Friday’s high of 1,208 keeps our upper near-term target of 1,225 in play but the finish back below 1,200 was frustrating for the bulls. We have talked about their wiggle room down to 1,190 but any dips below this level needs to be watched as it gets 1,175 in play. A close below this wave of support would be bearish for another possible test to 1,150-1,125. The Russell came into Monday’s open at 1,181 and put up a 12-pack, or 1%, for the week. YTD, the small-caps are in the green by 30 points, or 2.6%.
The S&P 500 Volatility Index ($VIX, 15.00, up 0.48) ended in no man’s land on Friday as it did neither the bulls or bears any favors. The VIX came into the week at 17.82 and triggered some nervousness on the prior Friday’s close above 17.50. Monday’s open at 16.39 was the go signal the week would be positive as the bulls pushed 15.37 and a close of 15.64. We wanted to see a close below 15 on Tuesday and that we got as the index ended at 14.53 and kissed 14.16. The bulls needed to hold 15 following Yellen’s comments on Wednesday and while the bears made a run to 15.95, the close at 14.95 was picture perfect. There was a test to 15.62 on Thursday’s open but the bulls managed to get the VIX down to 14.50 by the closing bell. Friday’s high reached 15.17 before the bulls tagged 13.77 but the finish at 15 was neutral. We have talked about the bulls needing to get below 13.50 to confirm the run to fresh all-time highs and a test to 11 could come on a blow-off the roof type last hurrah rally. Meanwhile, another close above 17.50 would be troublesome as it might suggest the highs are in. However, the new “flinch” target is now 18.50 (was 17.50 before the prior Friday close) and when we would start actively looking at put positions or going short. Any moves above these levels could lead to 20-22.
The bulls made a nice recovery off the prior week’s test to support but Wall Street wasn’t celebrating as more and more slick talking pros are calling for a pullback. Words and terms like “frothy”, “bubblicious”, “toppy”, and “irrational” were used to describe the push to new highs but it made no sense as the market was indeed reaching fresh highs.
While the action on Friday wasn’t thrilling, the movement for the week was bullish and the current environment is playing out a lot like last year. Fund managers are underperforming the market as most pros pencil-in their usual 5%-8% advance for the year and are now playing catchup. They have missed the momentum stocks and they have been waiting for the mother of all pullbacks to get the chance to get in. It is that simple. The hated rally from 2013 is still here.
With gains of 25%-30% across the board in 2013, it can be hard to expect the same types of moves in 2014 for the major indexes. However, the 10-year chart work we did in late February showed a good possibility for gains up to 20% for 2014.
For new subscribers, our possible yearend upside targets are Dow 19,000 (+15%); S&P 2,100 (+14%; Nasdaq 4,800-5,000 (+15%-20%); and for the Russell 1,400 (+20%).
We have also listed some nasty downside targets: Dow, 14,000 (-16%); S&P 1,550 (-16%); Nasdaq 3,200 (-23%) and for the Russell 950 (-18%) – if the 10-year uptrend lines fail to hold.
We do expect, at some point this year, there could be a pullback, correction, or selloff but there will be plenty of warning signs so we aren’t too worried about one if and when it happens. We would love to see a correction in the 10%-20% magnitude because we also play the short side but for now we are playing the cards being dealt.
We mentioned if the bulls recovered last week there could be the possibility of the current trading range extending into April. This might be when there could be a market top (maybe not) but no damage was done by the bears last week. This doesn’t mean they can’t strike quickly but we talked about the market entering a possible sweet spot to coincide with an April high once there is a breakout (or breakdown) out of the trading range.
Again, Friday’s action was slightly disappointing but there were a couple of factors that weighed on Tech and the blue-chips.
To start, Biotech stocks are struggling and were a major drag on Friday. We saw cracks throughout the week as some of the Biotech plays we have open in our Daily and Weekly Wrap suffered setbacks. The sector was a big influence in leading 2013 higher and the stocks have done well in 2014 but they were absolutely hammered on Friday.
Much of the pressure came from the zombies who are taxing medical instruments and are starting to look at the high costs associated with some of the most promising drugs coming to market.
Gilead Sciences (GILD, $72.07, down $3.46) sank nearly 5% on Friday after a few Democrats questioned the costs associated with the high price of the company’s hepatitis C drug, Sovaldi. Each pill is $1,000 and a cycle costs $84,000 for patients. This is a tremendously high cost to taxpayers but so is the US debt budget.
The success rate for patients taking Sovaldi is 90% with less side effects versus a previous success rate of about half with more serious side effects using other therapies.
Biotech stocks make up a good portion of the PowerShares QQQ Trust (QQQ, $89.00, down $1.29) and the selloff in the sector helps explain much of Friday’s weakness in the Nasdaq.
There are a number of ways to get a quick snapshot of the sector by following the Market Vectors Biotech ETF (BBH, $94.16, down $4.85), Nasdaq Biotechnology Index ($NBI, 2,577, down 119), or the S&P Biotech Spiders (XBI, $153.15, down $6.68). All were down over 4% on Friday.
The test to the 50-day MA’s on the Biotech ETF’s could be an early warning signal more trouble is ahead for the sector.
We covered Nike’s (NKE, $75.21, down $4.06) stellar earnings report on Friday and how they spooked Wall Street with their currency remarks going forward. Shares were down 3% in our midday update but we said they looked like they could be headed to $75 as there was continued weakness into the close. Friday’s low was $75 on the button and we mentioned there could be risk to $70.
The 5% drop into the close accounted for 26 negative Dow points. Goldman Sachs (GS, $166.95, down $2.27) accounted for 14 red points and if these 2 Dow components would have finished flat, the Dow would have been up a dozen points on Friday.
We would be surprised but not shocked if Nike shares did test $70 as the close below both the 50-day and 100-day MA’s was extremely bearish. The 200-day MA is just north of $71 and the uptrend line at $72.
There is wiggle room down to $74 and if this level holds on Monday, there might be a short-term bounce back to $78. We would look at April call options to play the possible move but a dip below $74 might suggest a short-term put option trade. Nike is on our Daily Watch List for next week.
The Financial stocks also pulled back following a decent week as we mentioned the first part of the bank stress tests would be bullish. We expected a “sell the news event” on Friday despite 29 of the 30 largest banks getting a passing grade from the Fed to withstand another financial crisis if one were to occur.
The second part of the bank stress tests are due out after Wednesday’s close and will determine if banks are holding adequate levels of capital required under the new reforms. If so, the banks would then be allowed to deploy even more of their capital back into “the system” for dividends and share buybacks. This would be more bullish than last week’s news and why Wall Street took a wait-and-see attitude. If the Financial stocks can raise their dividends, they should continue to push new highs.
We mentioned it would be important for the Financial Select Spiders (XLF, $21.80, down $0.14) to hold its 50-day MA and that we wanted to see a close back above $22 last week. The close at $22.03 on Monday easily relieved any concerns we had and by Friday the Financial Spiders reached a 52-week peak of $22.65. A run to $24-$25 into April would is possible on continued strength.
We often talk about the importance of Monday/ Friday closes and how much of this year’s action has occurred on these days.
For March, the Dow fell 153 points on the first Monday and gained 31 points the following Friday. There was a 34 point dip on the 10th and a 43 point drop on the 14th. St. Patty’s 181 point pop coupled with this past Friday’s fall make it 2 down/ 1 up Monday’s and 2 down/ 1 up Friday’s for the blie-chips. This is a bearish sign but the losses on the Monday/ Friday closes have been minimal and the 1% pop and drop on the big Monday’s offset each other.
Although stretched to the upside and downside, it confirms our theory a trading range would develop. Remember, solid up Friday and Monday’s are usually bullish as it means money is moving or staying in the market. Down and ugly Monday/ Friday’s can indicate cash is moving out of the market and mixed M/ F closes can spell trading ranges.
March is historically a bullish month but we have been warning the back half can be bearish as some of the bloom comes off the rose. There have been some nasty losses over the past decade during the last week of March as fund managers lock-in first quarter gains (if they have any) and the quarterly rebalance of the indexes. While this will be the last week, the end of the month occurs next Monday.
At current levels, the Dow is down 19 points for the month, the S&P 500 is up 7 points, the Nasdaq is lower by 32 points, and the Russell 2000 has gained over 10 points, or nearly 1%.
We mentioned at the start of the year the small-caps (and Tech) could outperform in a higher market and we will zone in on the small-caps and 1,171.87 as our major clue for the week. This was the mid-month low and just below support at 1,175. A break below 1,170 would be a clear warning sign the bears are waking up.
This clue, along with the VIX, the Monday/ Friday close, and the bank stress test news should determine if there is a continued run to new highs or a continued trading range with the possibility of fresh lows.
If the bulls can make it through this week without giving up ground or at least hold the first waves of support, April will be looking good.
As we head from desk to press: Dow futures are up 12 points to 16,233 while the S&P 500 futures are higher by 2 point to 1,859. The Nasdaq 100 futures are advancing 3 points to 3,642.
= = = = = = = = = = = = = = =
2. Symantec (SYMC) – A Falling Knife or Ready to Rebound?
By Michael Bryant
Key of Technicals Used In Following Article
March Madness has lived up to its name in college basketball and Friday was a very upsetting day for Symantec (SYMC, $18.20, down $2.70) shareholders. The stock plunged nearly 13% due to the firing of CEO Steve Bennett who will be temporarily replaced by board member Michael Brown as Symantec searches for a permanent CEO. Often a change in management is a good thing for a company that has seen two quarters of declining year-over-year revenue and disappointing sales. So, is the stock near a bottom and a good buy or is it a falling knife?
Founder Gary G. Hendrix graduated from the University of Texas in May 1970 and received a master’s degree in computer science there in December 1970. The Advanced Research Projects Agency, an agency of the Department of Defense responsible for developing new technologies for the military, announced funding for six projects in natural language understanding in 1970. Natural language understanding deals with bridging the gap between human language (such as English) and computer language. This influenced his decision to study in artificial intelligence, and in January 1971, he enrolled in the PhD program at the University of Texas. His research professor was Dr. Robert Simmons, who was into computational linguistics and well-known around the world.
While at the University of Texas, Hendrix published several papers on robotics and planning, which was read by several people from SRI International, which was founded as the Stanford Research Institute but separated from Stanford University in 1970. This led to an invitation for him to work at SRI. There he met Charlie Rosen, who had started the Artificial Intelligence Center. In 1978, he gathered fifteen employees from SRI to form Machine Intelligence Corporation from Charlie’s living room. Each put up five thousand dollars to initially fund the company, whose first project was robot vision. To raise additional funding, they submitted a proposal, using the Apple II running Pascal, to the National Science Foundation for using natural language processing to help in the manufacturing process. But despite also partnering with a Japanese company, Machine Intelligence failed in 1981 due mainly because it cost more to put scientists into an assembly line to set up the equipment than the equipment cost.
Hendrix then returned to SRI International to try again at forming his own company, and again with the help of a National Science Foundation grant, he founded Symantec Corporation in 1982. The company’s name came from semantic knowledge, the ability to discern and identify the meaning of symbols and words. The company focused on artificial intelligence-related projects, and Hendrix hired several Stanford University natural language processing researchers. To finance the company, he went to an American Electronics Association financial conference in Monterey, California in May 1983. After demonstrating the program which was started at Machine Intelligence, the company received venture capital.
In 1984, the company was acquired by another software startup company, C&E Software, founded by Denis Coleman and Gordon Eubanks. The merged company retained the name Symantec. C&E Software was in the process of developing an integrated file management and word processing program, and this was combined with technology created by Hendrix. In 1985, the company shipped its first major product, Q&A for the IBM-compatible PC. Q&A was a database program and was one of the few database management software packages for personal computers that used natural language query, based on an internal vocabulary of nearly 600 words. Sales for 1985 totaled $1.4 million.
After six years of losses, the company finally became profitable in 1988. And on June 23, 1989, it went public with listing on NASDAQ stock exchange. A year later, it acquired Peter Norton Computing, which has led to its highly successful Norton product line. The purchase helped Symantec, whose utility products were more heavily weighted towards the Macintosh platform, expand into the PC utilities market.
Today, the company has a 19.6% market share in computer security, ahead of Intel’s (INTC) McAfee with an 8.8% share. It also has a 16% market share in the $3.5 billion storage market, thanks to its $14 billion acquisition of data storage company Veritas in June 2005. However, the storage unit has caused many headaches for Symantec. CEO Steve Bennett was brought in to fix these headaches and strengthen the company’s growth. Despite cutting costs and reorganizing the sales force, revenue fell. Now since Bennett is gone, a possible sale of the storage unit is a possibility. Meanwhile, the company expects revenue to drop 8% during the current quarter, partly due to the falling PC market.
In the 4th quarter of fiscal 2013, the company restructured into three business segments:
- User Productivity & Protection: segment focuses on making it simple for customers to be productive and protected at home and at work. Products include our endpoint security and management, encryption, and mobile offerings.
- Information Security: segment focuses on keeping businesses safe and compliant, regardless of the size, location, or complexity of their infrastructure. Products include our next generation security capabilities, such as mail and web security, authentication services, data center security, managed security services, hosted security services, and data loss prevention.
- Information Management: segment offers backup and recovery, information intelligence (which includes archiving and e-discovery), and information availability (or storage management).
On May 7th after the bell, the company will report 4th quarter results for the three months ending March 31st. Analysts estimate the company will earn $0.42 per share on $1.64 billion.
Analysts see earnings plunging in the 4th quarter but growing slightly in the 1st quarter. So there seems a chance the shares will bottom soon.
The company’s major competitors are McAfee, a subsidiary of Intel (INTC), privately-held Trend Micro, and Microsoft (MSFT). In 2010, McAfee was purchased by Intel for $48 a share or $7.68 billion. Since Symantec’s market share is about 2.2 times that of McAfee, one could give a rough estimate of $17.0 billion on Symantec’s security business. Some other competitors are Palo Alto Networks (PANW), FireEye (FEYE), Barracuda Networks (CUDA) and privately-held Lookout. However, it has few pure-play competitors.
|
|
Current Month |
Last Month |
Two Months Ago |
Three Months Ago |
|
Strong Buy |
5 |
5 |
5 |
5 |
|
Buy |
8 |
8 |
9 |
9 |
|
Hold |
12 |
12 |
12 |
13 |
|
Underperform |
3 |
3 |
3 |
2 |
|
Sell |
0 |
0 |
0 |
0 |
= = = = = = = = = = = = = = =
3. Earnings
The companies in BOLD, we are looking at as possible trades and we may list call or put options on them in our Daily Newsletter. If they become official recommendations, we sent out Trade Alerts or include them in our 9am and 1pm updates that come out during the week (Quotes are from 3/21/14 close)
By Catherine Tierney
Monday
Before the open: Camelot Information Systems (CIS), China XD Plastics (CXDC), Hastings Entertainment (HAST), ReneSola (SOL), UnitedGuardian (UG)
After the close: American Apparel (APP), Charm Communications (CHRM), Dundee (DDEJF), Exa (EXA), Heska (HSKA), NQ Mobile (NQ), Rainmaker Systems (RMKR), USEC (USU)
Sonic (SONC, $21.27, down $0.32)
April 22.50 calls (SONC140419C00022500, $0.45, down $0.05)
April 20 puts (SONC140419C00020000, $0.40, up $0.10)
Thoughts: We have been following the stock since it was in the single-digits and we should have added it to our Weekly Wrap as a covered call trade a few years ago. Shares have been pushing 52-week peaks as Sonic has become the alternative to other well-known burger joints and another good earnings report could get shares near $24. However, if they use the weather excuse or low guidance, shares could fall below $20.
Tuesday
Before the open: Axion Power International (AXPW), Birner Dental Management Servi (BDMS), Cache (CACH), Carnival (CCL), Carnival PLC (CUK), CTI Industries (CTIB), Flamel Technologies (FLML), G-III Apparel Group (GIII), Goldfield Corp (GV), HD Supply Holdings (HDS), Highpower International (HPJ), Intelli-Check (IDN), McCormick (MKC), Neogen (NEOG), P & F Industries (PFIN), UniTek Global Services (UNTK), Vertex Energy (VTNR)
Walgreen (WAG, $64.75, down $1.75)
March 67.50 calls (weekly) (WAG140328C00067500, $0.55, down $0.50)
March 62.50 puts (weekly) (WAG140328P00062500, $0.60, up $0.30)
Thoughts: Walgreen’s has beaten estimates in 3 of the past 4 quarters. The average estimate is for the company to earn 92 cents a share. However, the high estimate is 97 cents while the low is 86 cents. This could mean a headline of a 5-6 cent miss or beat and why we have listed both calls and puts as a possible strangle trade. These options are WEEKLY options and expire this Friday. This means any trade should be taken Monday afternoon and possibly closed into Tuesday’s open.
After the close: Cyclacel Pharmaceuticals Inc (CYCC), Gevo (GEVO), Hampshire Group (HAMP), Landec (LNDC), PVH (PVH), Steelcase (SCS), Sungy Mobile Limited (GOMO), The9 (NCTY), Turquoise Hill Resources (TRQ), US Geothermal (HTM)
Five Below (FIVE, $38.59, down $0.24)
April 35 puts (FIVE140419P00035000, $0.95, up $0.10)
Thoughts: The company matched earnings estimates last time out but missed on revenue while lowering forward guidance. The fourth quarter and seasonal shopping got off to a slow start for Five Below and there could be an earnings miss this time around given the rough winter. If so, shares could stumble 10% as Price Targets in the $50’s by some brokerage firms get lowered. However, a good quarter might cause some short-covering and a move above $40 would crush the premium in these puts.
Wednesday
Before the open: Ever-Glory International Group (EVK), Francesca’s Holdingsoration (FRAN), Hooper Holmes (HH), Lindsay Manufacturing (LNN), Movado Group (MOVD), ProPhase Labs (PRPH), REX American Resourcesoration (REX), Uranium Resources (URRE)
After the close: Berkshire Bancorp (BERK), Charles & Colvard (CTHR), Comstock Homebuilding (CHCI), Digital Ally (DGLY), EXFO (EXFO), Genco Shipping & Trading (GNK), H.B. Fuller (FUL), Imperial Holdings (IFT), Kingold Jewelry (KGJI), LGL Group (LGL), Natuzzi (NTZ), PostRock Energy (PSTR), PrimeEnergy (PNRG), Quantum (DSS), Skystar Bio-Pharmaceutical (SKBI)
Paychex (PAYX, $42.84, down $0.08)
April 44 calls (PAYX140419C00044000, $0.40, down (0.05)
April 42 puts (PAYX140419P00042000, $0.55, down $0.05)
Thoughts: The company usually comes in a penny higher than estimates but shares seem to trade flat after the announcements. However, if earnings are light, shares could test $40.
Thursday
Before the open: Accenture (ACN), Altair Nanotechnologies (ALTI), Atalanta/Sosnoff Capital (ATL), Blonder Tongue Laboratories (BDR), China Automotive Systems (CAAS), Commercial Metals (CMC), Fred’s (FRED), Global Partners (GLP), Jos. A. Bank Clothiers (JOSB), Leidos Holdings (LDOS), lululemon athletica (LULU), On Track Innovations (OTIV), Revett Minerals (RVM), Saratoga Resources (SARA), Signet Jewelers (SIG), Superconductor Technologies (SCON), Tengasco (TGC), UTi Worldwide (UTIW),Vince Holding (VNCE), Winnebago Industries (WGO), Worthington Industries (WOR)
Conn’s (CONN, $33.41, up $0.10)
April 35 calls (CONN140419C00035000, $1.80, up $0.05)
April 30 puts (CONN140419P00030000, $1.30, down $0.10)
Thoughts: Shares fell over 40% in late February from nearly $56 to under $32 after the company shocked Wall Street with an earnings warning. Conn’s lowered their 2014 and 2015 profit forecasts so much of this news is already baked into the cake and makes it tempting to go long. However, another lousy quarter could easily push shares into the mid-$20’s. This might be a good strangle trade to consider if the premiums were cheaper but they are expensive for near-term strike prices. Overall, there is too much risk and not enough reward for us to feel comfortable taking either side of the trade.
GameStop (GME, $37.82, down $0.62)
April 34 puts (GME140419P00034000, $0.75, up $0.10)
Thoughts: We have always thought the company has way too many stores but their growth seemed to imply this was okay because GameStop has topped estimates for 4-straight quarters. However, beats have been by 7,6,5 and a penny, most recently, suggesting growth has slowed. The 52-week high is north of $57 and the yearly low is just above $25. We are more bearish than bullish on the stock as we feel shares have been overvalued since the move past $20 over a year ago.
After the close: Aehr Test Systems (AEHR), Astea International (ATEA), BioFuel Energy (BIOF), CPFL Energia (CPL), Dover Saddlery (DOVR), Interphase (INPH), MediciNova (MNOV), NTN Buzztime (NTN), Oxford Industries (OXM), Progress Software (PRGS), Re/Max Holdings (RMAX), Red Hat (RHT), Restoration Hardware Holdings (RH), Stratus Properties (STRS)
Friday
Before the open:
BlackBerry (BBRY, $9.18, down $0.24)
April 10 calls (BBRY140419C00010000, $0.45, down $0.10)
April 9 puts (BBRY140419P00009000, 0.65, up $0.15)
Thoughts: We don’t trust shares enough to go long and would be hesitant to short. These options together could also be looked at as a possible strangle option trade. The breakeven points are north of $11 and south of $8 by mid-April based on the $1.10 in premium.
Finish Line (FINL) (current Daily option trade recommendation)
After the close: Canterbury Park Holding (CPHC), LGI Homes (LGIH)
= = = = = = = = = = = = =
4. Weekly Wrap Covered Call Portfolio Update (Closing prices as of 3/21/14)
Our Weekly Wrap Closed Trade Track Record for 2014 is 12-3, or 80% win rate (97-10, or 91% win rate, overall since the start of 2011).
Special Notice: Our Opko Health (OPK, $9.35, down $0.32) LEAP Option Trade ran out of time as the March 10 calls expired out-of-the-money. Shares made a trip to $10.15 to start the week but the weakness in Biotech, overall, was to much to overcome. This drops our Track Record to 2014 to 12-3.
We did well by closing a number of trades earlier this month as we protected the portfolio from the prior week’s pullback. We like all of our current positions even though several are down and why we have traded lower priced stocks. We will need to find undiscovered gems, or wait for better entry prices on some other stocks we like before we start new positions. We haven’t shorted too many stocks but we may start looking at overpriced stocks and possible longer-term put plays if and when a top is put in.
Current Trades
Alexza Pharmaceuticals (ALXA, $4.89, down $0.06) Covered Call Trade
Sold June 6 calls (ALXA140621C00006000, $0.20, flat)
Original Entry Price: $5.53 (3/4/14)
Lowered Price from Selling Options: $5.03
Exit Target: $6+
Return: -3%
Stop Target: $3
Action: Shares fell below $5 and the 100-day MA to start the week and tested the 200-day by week’s end. Friday’s low reached $4.80 and a close below this level could lead to $4.60. Short-term resistance is now at $5.
On 3/4/2014 we recommended buying shares at $5.53 and selling the June 6 calls for 50 cents to lower our cost basis to $5.03. If we are called away in mid-June at $6 the trade will make 20%.
Zynga (ZNGA, $4.95, down $0.13) Covered Call Trade
Sold April 6 calls (ZNGA140419C00006000, $0.06, down $0.02)
Original Entry Price: $5.63 (3/4/14)
Lowered Price from Selling Options: $5.33
Exit Target: $6+
Return: -7%
Stop Target: $3
Action: Shares traded to a low of $4.87 on Friday and there is wiggle room down to $4.80. A close below this level would likely lead to $$4.65 and the 50-day MA. A close back above $5-$5.20 would be bullish but we won’t get excited until $5.40 clears again.
The company has some new games coming out over the next few months including a slick new version of Zynga Poker. We believe the company is a takeover target based on the potential revenue poker could bring to the company although Zynga doesn’t plan to monetize anytime soon. Perhaps Carl could shake up the board because there is billions to be made if Zynga can monetize their poker app.
On 3/4/2014 we recommended buying shares at $5.63 and selling the April 6 calls for 30 cents to lower our cost basis to $5.33. If we are called away in mid-April at $6 the trade will make 13%.
Galena Biopharma (GALE, $2.92, down $0.07) LEAP Trade
October 7 calls (LEAPs) (GALE141017C00007000, $0.40, flat)
Original Entry Price: $1.15 (2/10/13)
Exit Target: $2.30
Return: -65%
Stop Target: None
Galena Biopharma (GALE, $2.92, down $0.07) Stock Trade
Original Entry Price: $5.17 (2/10/14)
Lowered Price from Selling Options: $5.17
Exit Target: $10
Return: -44%
Stop Target: $2.50, lower to $1.75 (Hard Stop)
Action: Galena reported earnings last Monday and traded to a low of $2.54 after the company aired its dirty laundry. The $0.46 loss was overlooked as Wall Street focused on the SEC investigation. Two brokerage firms came out on Wednesday and defended the stock saying the shakedown should not affect the value of the company’s assets. We mentioned the negative news involving their knuckleheads managers would crush the momentum in the stock as we had some tremendous profits riding the wave from under $3 to nearly $8. We still like the company’s pipeline and hopefully Galena’s management has no more shenanigans up their sleeves. However, we have set a Hard Stop at $1.75 in case shares continue in their downward channel.
Discovery Laboratories (DSCO, $2.49, up $0.03) Covered Call Stock/ Option Trade
Sold April 3 calls (DSCO140419C00003000, $0.xx, flat)
Original Entry Price: $2.42 (1/7/14)
Lowered Price from Selling Options: $2.17
Exit Target: $4.50-$5
Return: 1%
Stop Target: $1
Action: Shares made a run at $2.50 and resistance last week and a level that served as prior support. Short-term resistance is at $2.60-$2.70 on a close above this level. A close below $2.20 will likely lead to $2 and the 200-day MA.
On 1/7/2014 we recommended buying shares at $2.42 and selling the April 3 calls for 25 cents to lower our cost basis to $2.17. If we are called away in mid-April at $3 the trade will make 39%.
Pizza Inn Holdings (PZZI, $5.55, down $0.25) Stock Trade
Original Entry Price: $8.10 (10/11/13)
Lowered Price from Selling Options/ Dividends: No options available
Exit Target: $12+
Return: -31%
Stop Target: $5
Action: We are disappointed with the continued slide in shares of Pizza Inn but it is a microcap stop we firmly believe in. Although the pizza wars are extremely competitive, the company will have experienced restaurants owners running their franchises and the Pie Five restaurant won the “Hot-Concept” restaurant award in 2012.
We said there was still risk to $5.75 but Thursday’s dip to $5.60 was a warning sign lower levels might come into play. The first level to watch for is $5.25.
Some recent bearish articles have questioned the company’s growth and earnings but we like their management team and they will need a little time to prove themselves once the first 100 stores are up and running. A close back above $6 would indicate the smart money is still staying in.
The company has 150 Pie Five shops opening this year and is expanding rapidly. We believe this will be a $15-$20 stock in 1-2 years and insiders and mutual funds own nearly 40% of the company.
DryShips (DRYS, $3.48, down $0.01)
Original Entry Price: $5.25 (1/3/11)
Lowered Price from Selling Options: $4.60
Exit Target: $5
Return: -24%
Stop Target: $2
Action: There is still risk to $3.20-$3 but shares are trying to clear their 50-day and 100-day MA’s. This would be mildly bullish but we would wait for $3.80 to clear before starting new positions.
Trades on HOLD (5): AKS Steel Holding (AKS), Rambus (RMBS)
Bebe Stores (BEBE) private equity offering coming north of $9?, Vivus (VVUS), Dendreon (DNDN)
= = = = = = = = = = = = = = =
5. Week Ahead
Here is a chart of the events for the week ahead:































